Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes

Published:2005-05-15 Issue:10 Volume:11 Page:3604-3608
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kaminskas Edvardas,Farrell Ann,Abraham Sophia,Baird Amy,Hsieh Li-Shan,Lee Shwu-Luan,Leighton John K.,Patel Hasmukh,Rahman Atiqur,Sridhara Rajeshwara,Wang Yong-Cheng,Pazdur Richard

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 355 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel mechanism by which c-MYC is aberrantly activated by epigenetic silencing in cancer cells;2024-09-13

2. Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy;Frontiers in Molecular Medicine;2024-09-06

3. 5-aza-2′-deoxycytidine induces telomere dysfunction in breast cancer cells;Biomedicine & Pharmacotherapy;2024-09

4. Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma;Acta Neuropathologica Communications;2024-08-07

5. Histone deacetylases and inhibitors in diabetes mellitus and its complications;Biomedicine & Pharmacotherapy;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP